The future of allergy treatment
How a child's simple request led to an extraordinary breakthrough in peanut allergy treatmentNOTRE DAME, Ind., Feb. 24, 2026 /PRNewswire/...
Read moreDetailsHow a child's simple request led to an extraordinary breakthrough in peanut allergy treatmentNOTRE DAME, Ind., Feb. 24, 2026 /PRNewswire/...
Read moreDetailsCOSTA MESA, Calif., Feb. 24, 2026 /PRNewswire/ -- Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening...
Read moreDetailsIBADAN, Nigeria, Feb. 24, 2026 /PRNewswire/ -- In a major milestone for eye health in Africa, HelpMeSee, in collaboration with...
Read moreDetailsCHICAGO, Feb. 24, 2026 /PRNewswire/ -- Physician Growth Partners ("PGP"), a leading sell-side healthcare investment banking firm, is pleased to...
Read moreDetailsSOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its...
Read moreDetailsPreviously unpublished clinical data support the potential long‑term safety and efficacy of collagenase clostridium histolyticum (CCH) for plantar fibromatosis.The findings...
Read moreDetailsPRINCETON, N.J., Feb. 24, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused...
Read moreDetailsFamilies and Communities Can Help All Children Thrive Through Awareness and ActionROCKVILLE, Md., Feb. 24, 2026 /PRNewswire/ -- Childhood hearing loss is...
Read moreDetailsLAUSANNE, Switzerland, Feb. 24, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field...
Read moreDetailsStrong organic revenue growth1 in 2025 of 8% driven by all operating segmentsDriven by an exceptional Q4, full year operating...
Read moreDetails© 2025 World Lifestyler